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Ucar et al. reply:
MicroRNAs are important regulators of gene expression that are involved in almost all cellular processes. Previously, we showed that the genetic deletion of the miR-212/132 family leads to impaired ductal outgrowth during pubertal mammary gland development in female mice 1 . Transplantation experiments demonstrated a stromal origin for the phenotype, identified as a lack of terminal end buds (TEBs) and impaired collagen deposition around mammary ducts.
We showed that miR-212 and miR-132 are expressed exclusively by mammary stromal cells and target MMP-9. Absence of miR-212 and miR-132 leads to higher MMP-9 levels, resulting in impaired collagen deposition and hyperactivation of transforming growth factor (TGF)-b signaling, which consequently impairs epithelial cell proliferation 1,2 .
Recently, Remenyi et al. reported that, in an independently generated miR-212/132 knockout mouse line, a similar phenotype was not observed, as homozygous mutant female mice of this line could properly nurture their pups 3 . In the current study by Kayo et al., the authors report another independently generated miR-212/132 knockout mouse line, which also does not display the previously reported mammary gland phenotype 4 . These observations suggest that loss of miR-212 and miR-132 function alone is not the underlying cause of the observed mammary gland phenotype in our knockout mouse line.
During the generation of our targeting vector, we verified the sequences of both homology arms to ensure that no undesired mutations would be introduced into the Mir212-Mir132 genomic locus, which resides between the Hic1 and Ovca1-Ovca2 genes (Fig. 1a) . Moreover, four independent embryonic stem (ES) cell clones with the targeted replacement mutation were used to generate independent mouse lines, and all lines showed the same mammary gland phenotype. Therefore, the phenotypic discrepancy between our knockout mouse lines and those generated by others might be due to some unknown genomic regulatory sequences differentially deleted by our targeting strategy. To address this possibility, we aligned the genomic regions that were deleted by our targeting strategy with those affected in other strategies (Fig.  1b) . This alignment showed that we deleted a 290-bp sequence on the 3ʹ side of the Mir212-Mir132 locus not targeted by the other groups. Interestingly, this genomic region is poorly conserved among species in comparison to the high evolutionary conservation of the genomic regions differentially targeted by the other two groups. In silico searches for putative transcription factor binding sites and CpG islands in this region were uninformative.
Kayo and colleagues demonstrated the presence of a neomycin cassette in our knockout mouse line, but we observed the impaired ductal outgrowth phenotype independently of the presence or absence of the neomycin cassette ( Supplementary  Fig. 1) .
To explain the phenotypic discrepancy, Kayo et al. performed a transcriptome analysis using the mammary glands of male mice, as they claim that mammary gland development in males seemed unchanged, solely on the basis of wholemount staining data. Notably, this claim has not been substantiated with histological analyses of the mammary ducts in those male mice in the C57BL/6 background containing the neomycin cassette. Although we did not previously analyze mammary gland development in males, here we show that the levels of EpCAM (an epithelial marker) are lower in the mammary glands of miR-212/132-null males in the C57BL/6N background, which lacks the neomycin cassette, males in comparison to their wild-type littermates (Supplementary Fig. 2 ). This finding may suggest the presence of fewer epithelial cells in the mutant male glands. In their transcriptome analyses, Kayo and colleagues showed a dramatic downregulation of Hic1 levels in our homozygous mouse line in the C57BL/6 background for both males and females. By analyzing HIC1 expression in FACS-sorted cells, they claim that Hic1 is exclusively expressed in stromal cells, whereas miR-212 and miR-132 are expressed in both the epithelial and stromal compartments. These findings are in sharp contrast to earlier published findings by others that Hic1 transcripts are predominantly expressed in mammary epithelia, in particular, within ductal TEB structures 5 
(Gene Expression Omnibus (GEO) 25860014).
Similarly, a previous study demonstrated HIC1 protein expression in the epithelial compartments of the mammary gland by immunohistochemistry 6 .
To verify the claims of Kayo et al., we also analyzed the expression of EpCAM and the two major spliced variants of Hic1 in the mammary glands of both males and females in our mouse line in the C57BL/6N background by comparing the expression levels in homozygous mutants to those in their wild-type littermates (Supplementary Fig. 2) . To this end, we used splice variant-specific primers spanning the exonic boundaries to prevent any amplification from contaminating genomic DNA in the npg c o r r e s p o n d e n c e samples (Supplementary Note), unlike the exonic primers used by Kayo et al. Our results demonstrate that Hic1 variant 1 levels are slightly but not significantly reduced both in male and female mammary glands. In females, Hic1 variant 2 levels seemed unchanged, whereas, in male glands, the levels were also slightly but not significantly reduced.
Because earlier studies demonstrated that Hic1 is expressed by both mammary epithelial and stromal cells, the reduced levels of Hic1 are likely a consequence of the reduced number of epithelial cells in the mammary glands of both male and female mutants, demonstrated here by the observed reduction in EpCAM levels ( Supplementary Fig. 2 ).
In conclusion, although it is clear that loss of function for the miR-212/132 family by itself might not lead to the impaired ductal outgrowth phenotype, it is not likely that this phenotype is caused by Hic1 downregulation as suggested by Kayo and colleagues. Nevertheless, we suspect that the differentially deleted genomic region in our targeting strategy might contain a previously unrecognized cis-acting genomic regulatory sequence, and it will therefore be interesting to identify the function of this region in future studies. 
